Christopher U. Missling

Person

New York, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
A2-73 crystalline polymorph compositions of matter and methods of u...
- Patent number 12,180,174
- Issue date Dec 31, 2024
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cardiac dysfunction
- Patent number 12,138,240
- Issue date Nov 12, 2024
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-yl...
- Patent number 11,896,590
- Issue date Feb 13, 2024
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neurodevelopmental disorder therapy
- Patent number 11,839,600
- Issue date Dec 12, 2023
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
A2-73 as a therapeutic for insomnia, anxiety, and agitation
- Patent number 11,813,242
- Issue date Nov 14, 2023
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
A19-144, A2-73 and certain anticholinesterase inhibitor composition...
- Patent number 11,690,821
- Issue date Jul 4, 2023
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sigma-1 receptor agonist systolic blood pressure therapy
- Patent number 11,622,955
- Issue date Apr 11, 2023
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
A2-73 crystalline polymorph compositions of matter and methods of u...
- Patent number 11,498,908
- Issue date Nov 15, 2022
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neurodevelopmental disorder therapy
- Patent number 11,446,275
- Issue date Sep 20, 2022
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
A2-73 as a therapeutic for insomnia, anxiety, and agitation
- Patent number 11,337,953
- Issue date May 24, 2022
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cardiac dysfunction
- Patent number 11,071,723
- Issue date Jul 27, 2021
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Analgesic therapeutic and method, 1-(3-4(((1 R,3S,5S)-adamantan-1-y...
- Patent number 10,933,062
- Issue date Mar 2, 2021
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neurodevelopmental disorder therapy
- Patent number 10,888,543
- Issue date Jan 12, 2021
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
A19-144, A2-73 and certain anticholinesterase inhibitor composition...
- Patent number 10,813,907
- Issue date Oct 27, 2020
- ANAVEX LIFE SCINCES CORP.
- Christopher U. Missling
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Neurodevelopmental disorder therapy
- Patent number 10,507,196
- Issue date Dec 17, 2019
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
A19-144, A2-73 and certain anticholinesterase inhibitor composition...
- Patent number 10,441,563
- Issue date Oct 15, 2019
- Anavex Life Sciences Corp.
- Missling U. Christopher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-yl...
- Patent number 10,195,192
- Issue date Feb 5, 2019
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
THERAPY SELECTION AND TREATMENT OF NEURODEGENERATIVE DISORDERS
- Publication number 20240417798
- Publication date Dec 19, 2024
- Anavex Life Sciences Corp.
- Christopher U. MISSLING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-yl...
- Publication number 20240156810
- Publication date May 16, 2024
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEURODEVELOPMENTAL DISORDER THERAPY
- Publication number 20240066003
- Publication date Feb 29, 2024
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A2-73 AS A THERAPEUTIC FOR INSOMNIA, ANXIETY AND AGITATION
- Publication number 20240041818
- Publication date Feb 8, 2024
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A19-144, A2-73 and Certain Anticholinesterase Inhibitor Composition...
- Publication number 20230301961
- Publication date Sep 28, 2023
- Anavex Life Sciences Corp.
- Christopher U. Missling
- C07 - ORGANIC CHEMISTRY
Information Patent Application
A2-73 CRYSTALLINE POLYMORPH COMPOSITIONS OF MATTER AND METHODS OF U...
- Publication number 20230142424
- Publication date May 11, 2023
- Anavex Life Sciences Corp.
- Christopher U. MISSLING
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SIGMA-1 RECEPTOR AGONIST SYSTOLIC BLOOD PRESSURE THERAPY
- Publication number 20230071766
- Publication date Mar 9, 2023
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEURODEVELOPMENTAL DISORDER THERAPY
- Publication number 20220387373
- Publication date Dec 8, 2022
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A2-73 AS A THERAPEUTIC FOR INSOMNIA, ANXIETY, AND AGITATION
- Publication number 20220347149
- Publication date Nov 3, 2022
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANAVEX2-73 FOR THE TREATMENT OF GENETIC NEURODEVELOPMENTAL DISORDERS
- Publication number 20220249427
- Publication date Aug 11, 2022
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OPTIMIZED SIGMA-1 AGONIST METHOD OF RESPONDER SELECTION AND TREATMENT
- Publication number 20220226278
- Publication date Jul 21, 2022
- Anavex Life Sciences Corp.
- Christopher U. MISSLING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANAVEX2-73 FOR THE TREATMENT OF GENETIC NEURODEVELOPMENTAL DISORDERS
- Publication number 20220142968
- Publication date May 12, 2022
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CARDIAC DYSFUNCTION
- Publication number 20220096424
- Publication date Mar 31, 2022
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Neurodevelopmental Disorder Therapy
- Publication number 20210228532
- Publication date Jul 29, 2021
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-yl...
- Publication number 20210196708
- Publication date Jul 1, 2021
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SIGMA-1 RECEPTOR AGONIST SYSTOLIC BLOOD PRESSURE THERAPY
- Publication number 20210186920
- Publication date Jun 24, 2021
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A2-73 CRYSTALLINE POLYMORPH COMPOSITIONS OF MATTER AND METHODS OF U...
- Publication number 20210115004
- Publication date Apr 22, 2021
- Anavex Life Sciences Corp.
- Christopher U. MISSLING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A2-73 AS A THERAPEUTIC FOR INSOMNIA, ANXIETY, AND AGITATION
- Publication number 20210085637
- Publication date Mar 25, 2021
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A19-144, A2-73 and Certain Anticholinesterase Inhibitor Composition...
- Publication number 20210046038
- Publication date Feb 18, 2021
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Neurodevelopmental Disorder Therapy
- Publication number 20200246303
- Publication date Aug 6, 2020
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A19-144, A2-73 and Certain Anticholinesterase Inhibitor Composition...
- Publication number 20200038365
- Publication date Feb 6, 2020
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-yl...
- Publication number 20190167668
- Publication date Jun 6, 2019
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CARDIAC DYSFUNCTION
- Publication number 20190117615
- Publication date Apr 25, 2019
- Anavex Life Sciences Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEURODEVELOPMENTAL DISORDER THERAPY
- Publication number 20190022052
- Publication date Jan 24, 2019
- Anavex Life Science Corp.
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A 19-144, A2-73 AND CERTAIN ANTICHOLINESTERASE INHIBITOR COMPOSITIO...
- Publication number 20180177756
- Publication date Jun 28, 2018
- Anavex Life Sciences Corp.
- MISSLING U. Christopher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-y...
- Publication number 20180117035
- Publication date May 3, 2018
- Christopher U. Missling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Christopher U. Missling

Person

Patents Grantslast 30 patents

A2-73 crystalline polymorph compositions of matter and methods of u...

Treatment of cardiac dysfunction

Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-yl...

Neurodevelopmental disorder therapy

A2-73 as a therapeutic for insomnia, anxiety, and agitation

A19-144, A2-73 and certain anticholinesterase inhibitor composition...

Sigma-1 receptor agonist systolic blood pressure therapy

A2-73 crystalline polymorph compositions of matter and methods of u...

Neurodevelopmental disorder therapy

A2-73 as a therapeutic for insomnia, anxiety, and agitation

Treatment of cardiac dysfunction

Analgesic therapeutic and method, 1-(3-4(((1 R,3S,5S)-adamantan-1-y...

Neurodevelopmental disorder therapy

A19-144, A2-73 and certain anticholinesterase inhibitor composition...

Neurodevelopmental disorder therapy

A19-144, A2-73 and certain anticholinesterase inhibitor composition...

Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-yl...

Patents Applicationslast 30 patents

THERAPY SELECTION AND TREATMENT OF NEURODEGENERATIVE DISORDERS

Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-yl...

NEURODEVELOPMENTAL DISORDER THERAPY

A2-73 AS A THERAPEUTIC FOR INSOMNIA, ANXIETY AND AGITATION

A19-144, A2-73 and Certain Anticholinesterase Inhibitor Composition...

A2-73 CRYSTALLINE POLYMORPH COMPOSITIONS OF MATTER AND METHODS OF U...

SIGMA-1 RECEPTOR AGONIST SYSTOLIC BLOOD PRESSURE THERAPY

NEURODEVELOPMENTAL DISORDER THERAPY

A2-73 AS A THERAPEUTIC FOR INSOMNIA, ANXIETY, AND AGITATION

ANAVEX2-73 FOR THE TREATMENT OF GENETIC NEURODEVELOPMENTAL DISORDERS

OPTIMIZED SIGMA-1 AGONIST METHOD OF RESPONDER SELECTION AND TREATMENT

ANAVEX2-73 FOR THE TREATMENT OF GENETIC NEURODEVELOPMENTAL DISORDERS

TREATMENT OF CARDIAC DYSFUNCTION

Neurodevelopmental Disorder Therapy

Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-yl...

SIGMA-1 RECEPTOR AGONIST SYSTOLIC BLOOD PRESSURE THERAPY

A2-73 CRYSTALLINE POLYMORPH COMPOSITIONS OF MATTER AND METHODS OF U...

A2-73 AS A THERAPEUTIC FOR INSOMNIA, ANXIETY, AND AGITATION

A19-144, A2-73 and Certain Anticholinesterase Inhibitor Composition...

Neurodevelopmental Disorder Therapy

A19-144, A2-73 and Certain Anticholinesterase Inhibitor Composition...

Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-yl...

TREATMENT OF CARDIAC DYSFUNCTION

NEURODEVELOPMENTAL DISORDER THERAPY

A 19-144, A2-73 AND CERTAIN ANTICHOLINESTERASE INHIBITOR COMPOSITIO...

Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-y...